Cognitive behavioural therapeutics for insomnia symptoms in the perimenopause through to the early postmenopausal period
Clinical Snapshot
PICO Framework
| P — Population | Women in perimenopause through to early postmenopausal period |
| I — Intervention | Cognitive behavioural therapy for insomnia (CBT-I) and cognitive behavioural therapy for menopausal symptoms (CBT-M) |
| C — Comparator | Not specified in protocol |
| O — Outcomes | Primary: sleep disturbances; Secondary: vasomotor symptoms, health equality impacts |
Bottom Line
This Cochrane protocol outlines a planned systematic review examining cognitive behavioural therapy interventions for sleep disturbances in perimenopausal and early postmenopausal women. The research question is well-focused and addresses a significant clinical need, as sleep problems affect up to 60% of women during menopause transition. The protocol appropriately distinguishes between CBT-I (targeting insomnia specifically) and CBT-M (addressing broader menopausal symptoms). Inclusion of health equity considerations is commendable. However, as this is only a protocol, no evidence synthesis or clinical recommendations are yet available. The completed review will be valuable for informing evidence-based management of menopausal sleep disturbances, particularly given the growing preference for non-hormonal interventions following concerns about hormone replacement therapy risks.
Key Findings
P Value: Not available - protocol stage
Effect Size: Not available - protocol stage
Primary Outcome: Sleep disturbances - not yet measured
Nnt Or Sensitivity: Not available - protocol stage
Confidence Interval: Not available - protocol stage
Clinical Application
CBT interventions are feasible in Australian healthcare settings with trained psychologists Relevant to Australian practice - CBT available through Medicare with GP referral, aligns with RACGP menopause guidelines emphasising non-pharmacological approaches Women experiencing sleep disturbances during perimenopause and early postmenopause
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary Objective i) To assess the effects of cognitive behavioural therapy for insomnia (CBT-I) and cognitive behavioural therapy for menopausal symptoms (CBT-M) on sleep disturbances in women in perimenopause through to the early postmenopausal period. Secondary Objectives i) To assess the effects of CBT-I and CBT-M on vasomotor symptoms in women in perimenopause through to the early postmenopausal period. ii) To assess the impact of socioeconomic status on the effectiveness of CBT-I and CBT-M, in order to determine the interventions' impact on health equality.
References
- 1.Breitinger-Blatt, D., Lee, J., Ribeiro Pereira, S. I., Smith, C., Gavriloff, D., & Sekaran, S. (2026). Cognitive behavioural therapeutics for insomnia symptoms in the perimenopause through to the early postmenopausal period. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD016349
Related Research
The Journal of rheumatology
Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review
3 Aug 2026
Journal of medical Internet research
Advancing Human-Centered AI in Clinical Decision Support: Sociocognitive Human-in-the-Loop Study in HIV Care
2 Aug 2026
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service